IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Decoy Therapeutics Inc (DCOY)

CUSIP: 79400X602 | NYSE | Healthcare · Biotechnology | Micro Cap | 8 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13GArmistice Capital, LLC65,50310.0%New 5%+ stakeJun 30, 2026No 13F filer matched
13GArmistice Capital, LLC65,503
10.0% of class · Jun 30, 2026

Institutional Holders — Q3 2026

Commonwealth Equity Services, LLC32,000
0.0% of portfolio›$63.0K
UBS Group AG4,525
0.0% of portfolio›$8.9K
SBI Securities Co., Ltd.111
0.0% of portfolio›$219
StyleTurnoverLocationFiled
Commonwealth Equity Services, LLC
32,000$63.0K0.0%ETFLowWaltham, MA2026-11-02
UBS Group AG
4,525$8.9K0.0%CoreMediumZurich, Switzerland2026-11-10
SBI Securities Co., Ltd.
111$2190.0%GrowthLowTokyo, Mexico2026-10-22
New 5%+ stake
No 13F filer matched